Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+93.8%
5Y CAGR+206.5%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+93.8%/yr
vs +385.8%/yr prior
5Y CAGR
+206.5%/yr
Recent deceleration
Acceleration
-292.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
270.4x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $16.22M | +27.9% |
| 2024 | $12.68M | +52.3% |
| 2023 | $8.32M | +273.7% |
| 2022 | $2.23M | +404.1% |
| 2021 | $442000.00 | +636.7% |
| 2020 | $60000.00 | +757.1% |
| 2019 | $7000.00 | +75.0% |
| 2018 | $4000.00 | - |